Clinical Trials Logo

Lung Function Decreased clinical trials

View clinical trials related to Lung Function Decreased.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05246930 Recruiting - Asthma Clinical Trials

Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma

Start date: June 15, 2022
Phase:
Study type: Observational

This study will determine if airway resistance to airflow and pressure, measured by Impulse Oscillometry, is impacted in subjects with vocal cord disorders and whether these measurements are different when compared to subjects with asthma.

NCT ID: NCT04859894 Recruiting - Covid19 Clinical Trials

Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation

Start date: April 20, 2021
Phase:
Study type: Observational

The physiological derangements in subjects suffering from long-term symptoms following a Covid-19 infection (Post-COVID-19 Syndrome) are poorly understood and evaluated. This study will recruit subjects with a clinical diagnosis of Post-Covid-19-syndrome) who are scheduled for either of lung function testing, cardiopulmonary exercise testing or cardiac ultrasound. Patients' symptoms will be correlated to physiological measures and compared to predicted values. In addition, in 20 patients, symptoms and physiological measures will be correlated to epigenetical alterations, or DNA-methylation patterns. In addition, a subset of patients will be examined a year after the baseline testing in order to follow the progress of the disease.

NCT ID: NCT04676828 Recruiting - Lung Cancer Clinical Trials

Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer

ASPECT
Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Study aims to determine if functional lung avoidance based on perfusion single photon emission (SPECT)/CT scan, improves toxicity outcomes for patients with advanced lung cancer undergoing chemo-radiotherapy. Functional avoidance implies a dose plan that takes functional distribution in the lung into account, and avoids highly functional lung volumes sparing them from radiation.

NCT ID: NCT04163146 Recruiting - Asthma in Children Clinical Trials

Lung Function Variability in Children and Adolescents

LUV
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Long-term variability analysis of peak expiratory flow (PEF) and forced expiratory volume in 1 s (FEV1) has been successfully used in research to predict the exacerbation of the disease in adult individuals with asthma. However, there is a paucity of data regarding PEF and FEV1 variability in asthmatic children and adolescents. Such a task requires at least daily PEF and FEV1 measurements, recording in diaries, and periodic evaluation of the data. The process may be proven both complicated and time consuming, thus reducing patients' adherence. Recent advances in biosensor technology have permitted the development of reliable, low-cost, portable spirometers, able to connect with smartphones and monitor lung function parameters in real time and from a distance. The objectives of the present study is the assessment of PEF and FEV1 variability: a) in healthy children and adolescents, in order to define the normal daily fluctuation of PEF and FEV1 and the parameters that may influence it, and b) in children and adolescents with asthma, in order to explore the differences from healthy subjects and reveal any specific variability changes prior to exacerbation. Such data would improve our understanding regarding the disease and permit the development of integrated tools for assessing the level of asthma control and the risk of future exacerbations. The study will include 100 healthy children and adolescents aged 6 to 18 years for the assessment of normal PEF and FEV1 variability, and 100 children and adolescents of the same age with diagnosed asthma for the assessment of PEF and FEV1 variability in asthmatics. PEF and FEV1 measurements will be performed using an FDA-approved portable spirometer (MIR Spirobank Smart) capable to connect to smartphone. Each participant will receive his personal spirometer. Measurements will be performed twice a day between 07:00-09:00 and 19:00-21:00 hours and dispatched via email to a central database for a period of 3 months. PEF and FEV1 variability will be assessed by detrended fluctuation analysis, aiming to define the normal pattern (healthy controls) and to detect and quantify the deviations (asthmatics). The anticipated duration of the study is 24 months.

NCT ID: NCT04081129 Recruiting - Critical Illness Clinical Trials

Effect of Early Mobilization on Regional Lung Ventilation Assessed by EIT

Start date: January 1, 2019
Phase:
Study type: Observational

Changes in pulmonary ventilation and perfusion by EIT to out-of-bed activity in critically ill patients

NCT ID: NCT03551197 Recruiting - Quality of Life Clinical Trials

Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary Disease

Start date: June 13, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the changes of lung function before and after the exercise in patients with chronic obstructive pulmonary disease.The assessment of quality of life is also carried out through questionnaires.

NCT ID: NCT03471884 Recruiting - Clinical trials for Non-small Cell Lung Cancer

Effects of Nonintubated Thoracoscopic Lobectomy on Lung Protection

Start date: March 2018
Phase: N/A
Study type: Interventional

A novel nonintubated thoracoscopic technique is promising to enhance recovery after thoracic surgery. However, the effects of nonintubated technique on specific organ protection in not clear yet. In this randomized trial, the effect of nonintubated technique on lung function protection will be evaluated via PaO2/FiO2 ratio, oxidative stress and inflammatory cytokines serially in lung cancer patients undergoing thoracoscopic lobectomy.